Inhaled ipratropium bromide added to beta2-agonists for hospitalized children with acute asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Ipratropium Bromide Added to Beta2-agonists for Hospitalized Children With Acute Asthma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458319/all/images/repview.
Inhaled ipratropium bromide added to beta2-agonists for hospitalized children with acute asthma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458319/all/images/repview. Accessed May 21, 2024.
Inhaled ipratropium bromide added to beta2-agonists for hospitalized children with acute asthma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458319/all/images/repview
Inhaled Ipratropium Bromide Added to Beta2-agonists for Hospitalized Children With Acute Asthma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 May 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458319/all/images/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled ipratropium bromide added to beta2-agonists for hospitalized children with acute asthma
ID - 458319
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458319/all/images/repview
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -